Empliciti earns FDA approval as combination multiple myeloma treatment
Bristol-Myers Squibb's drug Empliciti was approved by the Food and Drug Administration (FDA) Monday as a combination treatment for multiple myeloma, a form of blood cancer. Read More »
Alerts Sign-up